Arcus Biosciences Inc (NYSE:RCUS)
| 17.39 BATS BZX Real-Time Price As of 1:52pm ET |  +0.10 / +0.58%Today’s Change | 15.70 Today|||52-Week Range 36.13 | -15.91% Year-to-Date |
Institutional investors purchased a net $1.1 million shares of RCUS during the quarter ended June 2019. This may signal that the smart money is gaining interest in this company as the 68.79% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
| Individual stakeholders | 47.33% |
| Mutual fund holders | 42.64% |
| Other institutional | 26.15% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 8/31/2023 | PURPOSE INVESTMENTS, INC. Bought 3.0 Thousand shares of Arcus Biosciences Inc |
| 8/31/2023 | DFA AUSTRALIA LTD. Bought 409.00 shares of Arcus Biosciences Inc |
| 7/31/2023 | NORDEA INVESTMENT MANAGEMENT AB Sold 3.1 Thousand shares of Arcus Biosciences Inc |
Top 10 Owners of Arcus Biosciences Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| BlackRock Fund Advisors | 11.18% | 8,331,848 | 170,802,884 | -349,571 | -4.03% |
| Fidelity Management & Research Co... | 6.12% | 4,557,772 | 93,434,326 | +1,247,936 | +37.70% |
| SSgA Funds Management, Inc. | 5.83% | 4,342,248 | 89,016,084 | -1,154,005 | -21.00% |
| The Vanguard Group, Inc. | 5.81% | 4,331,681 | 88,799,461 | -9,228 | -0.21% |
| Octagon Capital Advisors LP | 2.64% | 1,968,000 | 40,344,000 | -204,000 | -9.39% |
| Balyasny Asset Management LP | 2.51% | 1,866,716 | 38,267,678 | +1,866,716 | -- |
| PFM Health Sciences LP | 1.89% | 1,405,056 | 28,803,648 | -154,891 | -9.93% |
| Columbia Management Investment Ad... | 1.73% | 1,290,487 | 26,454,984 | +1,095,452 | +561.67% |
| Dimensional Fund Advisors LP | 1.53% | 1,139,480 | 23,359,340 | -167,597 | -12.82% |
| AllianceBernstein LP | 1.40% | 1,040,431 | 21,328,836 | +22,502 | +2.21% |
Top 10 Mutual Funds Holding Arcus Biosciences Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| iShares Core S&P Small Cap ETF | 4.97% | 3,704,873 | 75,949,897 | +7,521 | +0.20% |
| Fidelity Select Port. - Biotechno... | 4.29% | 3,193,396 | 65,464,618 | 0 | 0.00% |
| SPDR S&P Biotech ETF | 3.48% | 2,590,761 | 53,110,601 | +36,593 | +1.43% |
| Vanguard Total Stock Market ETF | 1.95% | 1,454,232 | 29,811,756 | 0 | 0.00% |
| iShares Russell 2000 ETF | 1.59% | 1,184,825 | 24,288,913 | -1,672 | -0.14% |
| Pictet - Biotech | 1.14% | 846,612 | 17,355,546 | +10,852 | +1.30% |
| Vanguard Extended Market Index Fu... | 0.98% | 730,392 | 14,973,036 | -154 | -0.02% |
| Columbia Small Cap Growth Fund | 0.88% | 652,045 | 13,366,923 | 0 | 0.00% |
| Vanguard Small Cap Index Fund | 0.83% | 616,555 | 12,639,378 | +1,700 | +0.28% |
| S&P Small Cap 600 Growth ETF | 0.72% | 534,518 | 10,957,619 | 0 | 0.00% |